Loading...
Update on systemic treatment in early triple negative breast cancer
Triple negative breast cancer (TNBC) is a heterogeneous disease representing about 15% of all breast cancers. TNBC are usually high-grade histological tumors, and are generally more aggressive and difficult to treat due to the lack of targeted therapies available, and chemotherapy remains the standa...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7871289/ https://ncbi.nlm.nih.gov/pubmed/33613695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920986749 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|